Salvia Bioelectronics
Last verified 2026-05-08. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $53.0Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2024-04-01attributed |
| Founded | 2017 |
| Headquarters | Eindhoven, Netherlands |
| Industry | medtech |
| Stage | series-b+ |
| Website | salviabio.com |
Salvia BioElectronics develops a paper-thin implant that uses neuromodulation to reduce the frequency and intensity of chronic migraine and cluster headaches. It is built for severe migraine and cluster-headache patients. Its ultra-thin bioelectronic implant delivers gentle pulses to the nerves involved in migraine.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-04-01 | grant | $2.7M | undisclosed |
Detected tech stack
Cloudflare, reCAPTCHA, Google Sign-in, Google Tag Manager
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $53.0M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | salviabio.com, read 2026-05-08 |
| Description | self-reported | salviabio.com, read 2026-05-08 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.